$1.91
+0.06 (+3.24%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,130.9% upside
Low Target
$22.54
Average Target
$42.61
High Target
$49.20
Current Price
$1.91
Current
$1.91
$1.91
Target
$42.61
$42.61
$22.54
$42.61 avg
$49.20
Scenario Analysis
Bear Case
$22.54
1,080.1%
Low target
Base Case
$42.61
+2,130.9%
Avg target
Bull Case
$49.20
+2,475.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.56
-46.3% from high
52-Week Low
$1.25
+52.8% from low
Target vs 52W High
$42.61
+1,096.9% vs high
Next Earnings Report
Aug 19, 2026
3d
until earnings
EPS Est: $-0.51
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |